Injectable atypical antipsychotics for agitation in borderline personality disorder: A case report

J. C. Pascual; M. Madre; J. Soler; J. Barrachina; M. J. Campins; E. Alvarez; Victor Perez

doi:10.1055/s-2006-941489

Injectable atypical antipsychotics for agitation in borderline personality disorder: A case report

J. C. Pascual, M. Madre, J. Soler, J. Barrachina, M. J. Campins, E. Alvarez, Victor Perez

Research output: Contribution to journal › Article › Research › peer-review

27 Citations (Scopus)

Abstract

Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES). New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients. © Georg Thieme Verlag KG Stuttgart.

Original language	English
Pages (from-to)	117-118
Journal	Pharmacopsychiatry
Volume	39
Issue number	3
DOIs	https://doi.org/10.1055/s-2006-941489
Publication status	Published - 1 May 2006

Access to Document

10.1055/s-2006-941489

Cite this

@article{57a4ad2d1a29494eacd26eeaebad5f8f,

title = "Injectable atypical antipsychotics for agitation in borderline personality disorder: A case report",

abstract = "Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES). New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients. {\textcopyright} Georg Thieme Verlag KG Stuttgart.",

author = "Pascual, {J. C.} and M. Madre and J. Soler and J. Barrachina and Campins, {M. J.} and E. Alvarez and Victor Perez",

year = "2006",

month = may,

day = "1",

doi = "10.1055/s-2006-941489",

language = "English",

volume = "39",

pages = "117--118",

journal = "Pharmacopsychiatry",

issn = "0176-3679",

publisher = "Georg Thieme Verlag",

number = "3",

}

TY - JOUR

T1 - Injectable atypical antipsychotics for agitation in borderline personality disorder: A case report

AU - Pascual, J. C.

AU - Madre, M.

AU - Soler, J.

AU - Barrachina, J.

AU - Campins, M. J.

AU - Alvarez, E.

AU - Perez, Victor

PY - 2006/5/1

Y1 - 2006/5/1

N2 - Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES). New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients. © Georg Thieme Verlag KG Stuttgart.

AB - Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES). New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients. © Georg Thieme Verlag KG Stuttgart.

U2 - 10.1055/s-2006-941489

DO - 10.1055/s-2006-941489

M3 - Article

SN - 0176-3679

VL - 39

SP - 117

EP - 118

JO - Pharmacopsychiatry

JF - Pharmacopsychiatry

IS - 3

ER -

Injectable atypical antipsychotics for agitation in borderline personality disorder: A case report

Abstract

Access to Document

Fingerprint

Cite this